General Announcement::Appointment of Chief Financial Officer (CFO)

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
03-Nov-2017 00:51:29
Status
New
Announcement Sub Title
Appointment of Chief Financial Officer (CFO)
Announcement Reference
SG171103OTHRHABO
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
02/11/2017 20:00:00
Description (Please provide a detailed description of the event in the box below)
Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board at its Meeting held on November 2, 2017 have approved the appointment of Mr. V. S. Mani as President & Global Chief Financial Officer with effect from November 16, 2017 upon the recommendation of the Nomination and Remuneration Committee. Mr. P Ganesh, current President and Global Chief Financial Officer, has tendered his resignation to explore an opportunity outside the Company. The Board places on record its appreciation for contribution made by Mr. P Ganesh.

Kindly find enclosed herewith press release in this regard.

This is for your information and record.

Attachments

SGX_CFO.pdf
Total size =67K